Physician profile
Derek Ley
NPI 1992157788
$16,468.78
in general payments reported to CMS, 2019-2025
29 companies · $2,221 in 2025
The $2,221 reported for 2025 was more than what 85% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,618 · 2020: $1,368 · 2021: $4,405 · 2022: $834 · 2023: $1,251 · 2024: $1,773 · 2025: $2,221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,424 · Travel and Lodging: $1,820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,424.36 |
| Travel and Lodging | $1,820.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,932.72 | 2020-2025 | Prostep, Citrefix, Prophecy |
| Paragon 28, INC. | $3,623.54 | 2019-2021 | |
| Orthofix Medical, INC. | $2,252.07 | 2019-2025 | Truelok, Tl-Hex Truelok Hexapod System, Galaxy Fixation System |
| Medline Industries Lp | $1,229.07 | 2019-2024 | |
| Gemini Mountain Medical, LLC | $1,200.00 | 2021 | |
| Integra Lifesciences Corporation | $1,014.92 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| In2bones USA, LLC | $576.00 | 2020-2021 | |
| Core Surgical Group | $535.24 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $403.28 | 2019-2021 | |
| Organogenesis INC. | $301.21 | 2019-2022 | |
| Arthrex, INC. | $218.58 | 2022-2024 | |
| Pylant Medical | $208.35 | 2023-2024 | |
| Bone Support INC. | $158.42 | 2021 | |
| Kci USA, INC. | $149.08 | 2019 | |
| Voom Medical Devices, INC. | $129.83 | 2025 | Revcon |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $119.13 | 2019-2022 | |
| Acell, INC. | $79.15 | 2019 | |
| 3m Company | $55.25 | 2019 | |
| Kerecis Limited | $40.88 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Depuy Synthes Sales INC. | $35.64 | 2021 | |
| Treace Medical Concepts, INC. | $34.27 | 2022-2023 | |
| Bioventus LLC | $28.75 | 2021-2022 | |
| Misonix INC | $26.98 | 2019 | |
| Medinc of Texas | $26.03 | 2023 | |
| Derma Sciences, INC. | $24.44 | 2019 | |
| Anika Therapeutics, INC. | $21.00 | 2021 | |
| Crossroads Extremity Systems, LLC | $20.00 | 2021 | |
| Arteriocyte Medical Systems, INC. | $13.07 | 2022 | |
| Abbvie INC. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Ley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.